New Airway for Awake Intubation (McKay Airway)
A Pilot Study in Healthy Volunteers of McKay Airway - An Improved Oral Airway for Awake Fibre-optic Intubation
1 other identifier
interventional
71
1 country
1
Brief Summary
When endotracheal intubation is known or predicted to be difficult, patients are intubated awake using a flexible bronchoscope (awake fibre-optic intubation: AFI) so that they can protect their airway with normal upper airway muscle activity until the endotracheal tube (ETT) is safely in place. New bite blocks have been invented for bag mask ventilation but are not suitable for AFI.1 A newly invented airway device, the McKay airway, may provide a better solution for AFI by enabling jaw thrust, a condition where the upper airway is opened more as the jaw is protruded forward. It may also be more comfortable for awake users. A study is proposed to assess the functionality of the device for this purpose. To protect the bronchoscope, a bite block is used during AFI to protect the very delicate glass fibres from damage from inadvertent biting by the patient. Currently used bite blocks protect the scope, but do not position the jaw optimally for scoping. The proposed device is an attempt to improve upon current bite blocks by both protecting the bronchoscope and positioning the jaw optimally. Hypothesis: Residents in training in the Division of Respirology have limited experience in fibre-optic bronchoscopy and perform it under the direct supervision of an expert. Null hypothesis: the time to visualization of vocal cords with a fibre-optic bronchoscope by residents learning in the Division of Respirology will be no different with the McKay airway than with the conventional bite block or Williams Airway.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Apr 2018
Typical duration for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 4, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 25, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 25, 2019
CompletedFirst Submitted
Initial submission to the registry
August 7, 2019
CompletedFirst Posted
Study publicly available on registry
August 9, 2019
CompletedAugust 9, 2019
August 1, 2019
1.3 years
August 7, 2019
August 7, 2019
Conditions
Outcome Measures
Primary Outcomes (2)
Ease of use.
Ordinal scale comparison with standard bite block for ease of obtaining a bronchoscopic view of vocal cords or epiglottis (scale of 1 to 5 - see data sheets below).
5 minutes
Time to visualize cords.
Time in seconds from starting bronchoscope insertion to cord visualization.
5 minutes
Secondary Outcomes (1)
Usefulness.
5 minutes
Study Arms (3)
ConMed bite block
ACTIVE COMPARATORStandard bite block (Conmed Bite Block; Conmed Corp., Utica NY, USA)
Williams Airway
ACTIVE COMPARATORWilliams Airway Intubator (Williams Airway Intubator Ltd, Calgary, Canada)
McKay airway
EXPERIMENTALA new device that enables maintenance of jaw thrust. (US patent application 16/098,530)
Interventions
Investigator will fit ConMed bite block in patient's mouth and bronchoscopist will try to visualize the vocal cords.
Investigator will fit McKay airway in patient's mouth and bronchoscopist will try to visualize the vocal cords.
Investigator will fit Williams Airway in patient's mouth and bronchoscopist will try to visualize the vocal cords.
Eligibility Criteria
You may qualify if:
- Participants are of two kinds, first, anesthesiologists and anesthesia residents who will perform partial bronchoscopy, and
- secondly, healthy volunteers. Healthy volunteers will be recruited from hospital staff, residents and students at Royal University Hospital.
You may not qualify if:
- Excepted anesthesiologists and residents will be those who do not wish to participate in the study.
- Excepted volunteers will be those who do not wish to participate in the study and those with a lidocaine allergy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Saskatoon Health Region, 410 22nd Street East
Saskatoon, Saskatchewan, S7K 5T6, Canada
Study Officials
- PRINCIPAL INVESTIGATOR
William P McKay, MD
Professor Emeritus
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- M.D.
Study Record Dates
First Submitted
August 7, 2019
First Posted
August 9, 2019
Study Start
April 4, 2018
Primary Completion
July 25, 2019
Study Completion
July 25, 2019
Last Updated
August 9, 2019
Record last verified: 2019-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF, CSR
- Time Frame
- June 2017 - indefinitely
- Access Criteria
- Interested applicant
De-identified data (all) will be available from Dr McKay - email request